All Stories

  1. Chronic Low-Level IFN-γ Expression Disrupts Mitochondrial Complex I Activity in Renal Macrophages: An Early Mechanistic Driver of Lupus Nephritis Pathogenesis
  2. Interleukin-2-mediated NF-κB-dependent mRNA splicing modulates interferon gamma protein production
  3. D-Allulose Ameliorates Dysregulated Macrophage Function and Mitochondrial NADH Homeostasis, Mitigating Obesity-Induced Insulin Resistance
  4. IL-15 Priming Alters IFN-γ Regulation in Murine NK Cells
  5. Dual B-cell targeting therapy ameliorates autoimmune cholangitis
  6. Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression
  7. Double Negative T Regulatory Cells: An Emerging Paradigm Shift in Reproductive Immune Tolerance?
  8. Joost J. Oppenheim: 1934–2022
  9. Myeloid-Derived Suppressive Cell Expansion Promotes Melanoma Growth and Autoimmunity by Inhibiting CD40/IL27 Regulation in Macrophages
  10. Safety levels of systemic IL-12 induced by cDNA expression as a cancer therapeutic
  11. Using PET imaging to track STING-induced interferon signaling
  12. Cytokines: From Clinical Significance to Quantification
  13. Promise and complexity of lupus mouse models
  14. The Experts Speak: A New Feature in the JICR
  15. Lessons learned: new insights on the role of cytokines in COVID-19
  16. Natural Killer Cell Transcript 4 promotes the development of Sjӧgren's syndrome via activation of Rap1 on B cells
  17. IFNγ Is a Key Link between Obesity and Th1-Mediated AutoImmune Diseases
  18. Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair–deficient tumors
  19. Perforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients
  20. The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge
  21. Multi-omics: Differential expression of IFN-γ results in distinctive mechanistic features linking chronic inflammation, gut dysbiosis, and autoimmune diseases
  22. The Gut Microbiome and Xenobiotics: Identifying Knowledge Gaps
  23. Adaptive in vivo device for theranostics of inflammation: Real-time monitoring of interferon-γ and aspirin
  24. Meeting Overview: Interferon Lambda—Disease Impact and Therapeutic Potential
  25. Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study
  26. Ion Gresser 1928–2019
  27. IFN-γ: A cytokine at the right time, is in the right place
  28. Report on the 2018 Cancer, Autoimmunity, and Immunology Conference
  29. Thymic expression of IL-4 and IL-15 after systemic inflammatory or infectious Th1 disease processes induce the acquisition of "innate" characteristics during CD8+ T cell development
  30. Adaptive <i>in vivo</i> Device for Theranostics of Inflammation by Monitoring of Cytokine Interferon-γ and Its Triggered Aspirin Release
  31. Partners in Crime: Fledgling Tumors Hijack Inflammation
  32. Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells
  33. Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells
  34. Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells
  35. Interferon-Gamma Impairs Maintenance and Alters Hematopoietic Support of Bone Marrow Mesenchymal Stromal Cells
  36. Dr. Luigi (Gigi) Varesio: A memorial
  37. The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex-biased autoimmunity
  38. Early TCR Signaling Induces Rapid Aerobic Glycolysis Enabling Distinct Acute T Cell Effector Functions
  39. Interferon-Gamma
  40. Current prospects of type II interferon γ signaling and autoimmunity
  41. Toward solving the etiological mystery of primary biliary cholangitis
  42. Th1 Differentiation Drives the Accumulation of Intravascular, Non-protective CD4 T Cells during Tuberculosis
  43. Rapid and Rigorous IL-17A Production by a Distinct Subpopulation of Effector Memory T Lymphocytes Constitutes a Novel Mechanism of Toxic Shock Syndrome Immunopathology
  44. Therapeutic and immunological interventions in primary biliary cholangitis: from mouse models to humans
  45. Chronic expression of interferon‐gamma leads to murine autoimmune cholangitis with a female predominance
  46. CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
  47. Aging Converts Innate B1a Cells into Potent CD8+T Cell Inducers
  48. Interferon γ: An Overview of Its Functions in Health and Disease
  49. Regulation of IFN-γ Expression
  50. Architecture of high-affinity unnatural-base DNA aptamers toward pharmaceutical applications
  51. Surface display of glycosylated Tyrosinase related protein-2 (TRP-2) tumour antigen on Lactococcus lactis
  52. Short Course in the Microbiome
  53. NOS Inhibition Modulates Immune Polarization and Improves Radiation-Induced Tumor Growth Delay
  54. Sera from patients with active systemic lupus erythematosus patients enhance the toll-like receptor 4 response in monocyte subsets
  55. Impact of dietary components on NK and Treg cell function for cancer prevention
  56. IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation
  57. Does the microbiota play a role in the pathogenesis of autoimmune diseases?
  58. IFN-gamma AU-rich element removal promotes chronic IFN-gamma expression and autoimmunity in mice
  59. IFN-gamma causes aplastic anemia by altering HSC composition and interrupting lineage differentiation
  60. Interferons: Success in anti-viral immunotherapy
  61. Tumor microenvironment-based feed-forward regulation of NOS2 in breast cancer progression
  62. Abrogation of TNFα Production during Cancer Immunotherapy Is Crucial for Suppressing Side Effects Due to the Systemic Expression of IL-12
  63. Impaired HCV Clearance in HIV/HCV Coinfected Subjects Treated with PegIFN and RBV Due to Interference of IFN Signaling by IFNαR2a
  64. Faculty of 1000 evaluation for IL-4 blocks TH1-polarizing/inflammatory cytokine gene expression during monocyte-derived dendritic cell differentiation through histone hypoacetylation.
  65. Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever
  66. The Pivotal Role of IKKα in the Development of Spontaneous Lung Squamous Cell Carcinomas
  67. Molecular Pathways: Toll-like Receptors in the Tumor Microenvironment—Poor Prognosis or New Therapeutic Opportunity
  68. The talented interferon-gamma
  69. Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice
  70. Interleukin-18 in Pulmonary Inflammatory Diseases
  71. MCP‐1/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious/inflammatory processes
  72. Scientific Apps are here (and more will be coming)
  73. Distinct and overlapping genomic profiles and antiviral effects of Interferon‐λ and ‐α on HCV‐infected and noninfected hepatoma cells
  74. IFN-Gamma
  75. IFN-γ
  76. CS13-7. Loss of Ifn-g 3’Untranslated Region Au-rich Element Affects b220+ b Cell and Plasmacytoid Dendritic cell Populations in a Novel Murine Lupus Model
  77. Gut microbiota and probiotics in colon tumorigenesis
  78. Protein delivery using engineered virus-like particles
  79. Revamping Research Funding
  80. In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression
  81. Differential microRNA regulation of HLA-C expression and its association with HIV control
  82. Cutting Edge: Ku70 Is a Novel Cytosolic DNA Sensor That Induces Type III Rather Than Type I IFN
  83. Editorial: One small molecule: a new way to treat the flu?
  84. Localized Delivery of Interferon-β by Lactobacillus Exacerbates Experimental Colitis
  85. Interferon-γ links ultraviolet radiation to melanomagenesis in mice
  86. A novel role for IL-22R1 as a driver of inflammation
  87. Probiotics: From Bench to Market
  88. PS3-50 Differential transcriptosome profiles and antiviral effect of interferon-λ and interferon-α on HCV-infected and uninfected hepatoma cells
  89. CS3-5 miRNA interacts with AU-rich elements stabilizing interferon gamma gene
  90. SS4-4 Ku70 is a novel cytosolic DNA sensor and induces type-III IFN rather than Type-I IFN
  91. CS1-2 Targeted removal of IFN-gamma 3′untranslated region AU-rich element alters B cell function resulting in lupus-like disease in C57BL6 mice
  92. Interleukin-26: An IL-10-related cytokine produced by Th17 cells
  93. PL3-5 A novel role of IL-22R1 as a possible driver of inflammation in ALK+ anaplastic large cell lymphoma
  94. Interferon Therapy for Malignant Solid Tumors
  95. Clinical Use of Interferon-γ
  96. Role of Proinflammatory Cytokines IL-18 and IL-1β in Bleomycin-Induced Lung Injury in Humans and Mice
  97. An Overview of Cytokines and Cytokine Antagonists as Therapeutic Agents
  98. Lentiviral Gene Transduction in Human and Mouse NK Cell Lines
  99. Novel gene expression patterns in IFN-gamma 3′untranslated region AU-rich element-deleted mice
  100. Coexpression of IL-18 Strongly Attenuates IL-12-Induced Systemic Toxicity through a Rapid Induction of IL-10 without Affecting its Antitumor Capacity
  101. Interleukin-15 Enhances Proteasomal Degradation of Bid in Normal Lymphocytes: Implications for Large Granular Lymphocyte Leukemias
  102. Structural conservation of interferon gamma among vertebrates
  103. Cytokine Multiplex Analysis
  104. BCL11B enhances TCR/CD28-triggered NF-κB activation through up-regulation of Cot kinase gene expression in T-lymphocytes
  105. SY-12 The Role of miRNAs in the regulation of interferon-gamma gene expression
  106. 293 IFN-γ 3′untranslated region AU-RICH element-deleted mice have altered immune structure and function
  107. Conformationally Constrained Analogues of Diacylglycerol. 29. Cells Sort Diacylglycerol-Lactone Chemical Zip Codes to Produce Diverse and Selective Biological Activities
  108. Protein Kinase R-dependent Regulation of Interleukin-10 in Response to Double-stranded RNA
  109. In Vivo Regulation of Experimental Autoimmune Encephalomyelitis by NK Cells: Alteration of Primary Adaptive Responses
  110. Murine β-defensin 2 promotes TLR-4/MyD88-mediated and NF-κB-dependent atypical death of APCs via activation of TNFR2
  111. Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein c2
  112. A Novel Role of the Interferon-inducible Protein IFI16 as Inducer of Proinflammatory Molecules in Endothelial Cells
  113. Modulation of lymphocyte function with inhibitory CD2: Loss of NK and NKT cells
  114. The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever
  115. NKT Cell-Derived Urokinase-Type Plasminogen Activator Promotes Peripheral Tolerance Associated with Eye
  116. 54 Challenging Evolution: Eliminating the IFN-gamma 3 ARE Effects T Cell Homeostasis
  117. Pulmonary Inflammation and Emphysema
  118. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1–IRF-3 signaling axis
  119. Post-transcriptional control of the interferon system
  120. Hematopoiesis and Thymic Apoptosis Are Not Affected by the Loss of Cdk2
  121. NK Cell-Derived IFN-γ Differentially Regulates Innate Resistance and Neutrophil Response in T Cell-Deficient Hosts Infected with Mycobacterium tuberculosis
  122. The Proinflammatory Cytokine Interleukin-18 Alters Multiple Signaling Pathways to Inhibit Natural Killer Cell Death
  123. The Scaffold Protein Cybr Is Required for Cytokine-Modulated Trafficking of Leukocytes In Vivo
  124. Interferon-γ: Gene and Protein Structure, Transcription Regulation, and Actions
  125. IL-18 as critical co-stimulatory molecules in modulating the immune response of ITAM bearing lymphocytes
  126. TL1A: A mediator of gut inflammation
  127. An IFNG SNP with an estrogen-like response element selectively enhances promoter expression in peripheral but not lamina propria T cells
  128. Unraveling the Pros and Cons of Interferon-γ Gene Regulation
  129. Peroxisome proliferator activated receptor γ in colonic epithelial cells protects against experimental inflammatory bowel disease
  130. Regulation of ITAM-positive receptors: role of IL-12 and IL-18
  131. Conditional up-regulation of IL-2 production by p38 MAPK inactivation is mediated by increased Erk1/2 activity
  132. Cytokines as critical co-stimulatory molecules in modulating the immune response of natural killer cells
  133. Interleukin-10 and the immune response against cancer: a counterpoint
  134. Specific Inhibition of MyD88-Independent Signaling Pathways of TLR3 and TLR4 by Resveratrol: Molecular Targets Are TBK1 and RIP1 in TRIF Complex
  135. Thioredoxin suppresses airway hyperresponsiveness and airway inflammation in asthma
  136. Coactivators and Corepressors of NF-κB in IκBα Gene Promoter
  137. Cytokine-driven cell cycling is mediated through Cdc25A
  138. Dendritic Cells Endocytose Bacillus anthracis Spores: Implications for Anthrax Pathogenesis
  139. Synthesis and biological study of a flavone acetic acid analogue containing an azido reporting group designed as a multifunctional binding site probe
  140. Synergistic Effect of IL-2, IL-12, and IL-18 on Thymocyte Apoptosis and Th1/Th2 Cytokine Expression
  141. TGF-β and Vitamin D3 Utilize Distinct Pathways to Suppress IL-12 Production and Modulate Rapid Differentiation of Human Monocytes into CD83+ Dendritic Cells
  142. Mouse Ly49 NK receptors: balancing activation and inhibition
  143. Triptolide Attenuates Endotoxin- and Staphylococcal Exotoxin-Induced T-Cell Proliferation and Production of Cytokines and Chemokines
  144. Interleukin-10 Induces Uteroglobin-related Protein (UGRP) 1 Gene Expression in Lung Epithelial Cells through Homeodomain Transcription Factor T/EBP/NKX2.1
  145. Enhancer Role of STAT5 in CD2 Activation of IFN-γ Gene Expression
  146. Peroxisome proliferator-activated receptor-γ and its ligands attenuate biologic functions of human natural killer cells
  147. BCL-3 and NF-κB p50 Attenuate Lipopolysaccharide-induced Inflammatory Responses in Macrophages
  148. Mouse Susceptibility to Anthrax Lethal Toxin Is Influenced by Genetic Factors in Addition to Those Controlling Macrophage Sensitivity
  149. A Distal Region in the Interferon-γ Gene Is a Site of Epigenetic Remodeling and Transcriptional Regulation by Interleukin-2
  150. Distinct Regions of the Interleukin-7 Receptor Regulate Different Bcl2 Family Members
  151. Analysis of Murine Natural Killer Cell Microsomal Proteins Using Two-Dimensional Liquid Chromatography Coupled to Tandem Electrospray Ionization Mass Spectrometry
  152. Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection
  153. Proteomic investigation of natural killer cell microsomes using gas-phase fractionation by mass spectrometry
  154. Interleukin 2 plays a central role in Th2 differentiation
  155. Inactivation of Stat3 in tumor cells
  156. Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells
  157. Dissociation of NKT Stimulation, Cytokine Induction, and NK Activation In Vivo by the Use of Distinct TCR-Binding Ceramides
  158. Aging of innate immunity: functional comparisons of NK/LAK cells obtained from bulk cultures of young and aged mouse spleen cells in high concentrations of interleukin-2
  159. Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines
  160. Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event
  161. Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
  162. Pathogenesis of Ebola Hemorrhagic Fever in Primate Models
  163. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys
  164. IFN-  Polymorphisms (IFN-  +2109 and IFN-  +3810) Are Associated with Severe Hepatic Fibrosis in Human Hepatic Schistosomiasis (Schistosoma mansoni)
  165. Redox-active Protein Thioredoxin Prevents Proinflammatory Cytokine- or Bleomycin-induced Lung Injury
  166. Receptor Glycosylation Regulates Ly-49 Binding to MHC Class I
  167. Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells
  168. Bacillus anthracis lethal toxin induces TNF-α–independent hypoxia-mediated toxicity in mice
  169. The Four Distal Tyrosines Are Required for LAT-dependent Signaling in FcεRI-mediated Mast Cell Activation
  170. IL-4 synergistically enhances both IL-2– and IL-12–induced IFN-γ expression in murine NK cells
  171. Correction
  172. CD2 mediates activation of the IFN-γ intronic STAT binding region in mucosal T cells
  173. The distinct patterns of T cell IFN-γ promoter responses in LPMC are generated in PBL following IL-2 treatment
  174. Multiprobe Ribonuclease Protection Assay for Simultaneous Measurement of mRNA Expression
  175. Characterization of an interleukin-7-dependent thymic cell line derived from a p53−/− mouse
  176. Epigenetic Control during Lymphoid Development and Immune Responses
  177. Expression of IFN-γ Upon Triggering of Activating Ly49D NK Receptors In Vitro and In Vivo: Costimulation with IL-12 or IL-18 Overrides Inhibitory Receptors
  178. Interferon-γ
  179. Bax Deficiency Partially Corrects Interleukin-7 Receptor α Deficiency
  180. Redirecting Migration of T Cells to Chemokine Secreted from Tumors by Genetic Modification with CXCR2
  181. IL-7 withdrawal induces a stress pathway activating p38 and Jun N-terminal kinases
  182. PPAR and immune system—what do we know?
  183. IL-2 and IL-12 Alter NK Cell Responsiveness to IFN-γ-Inducible Protein 10 by Down-Regulating CXCR3 Expression
  184. Growth Factor Independent-1 Induced by IL-4 Regulates Th2 Cell Proliferation
  185. A single nucleotide polymorphism in the proximal IFN-gamma promoter alters control of gene transcription
  186. Reduced Expression of Nuclear Cyclic Adenosine 5′-Monophospate Response Element-Binding Proteins and IFN-γ Promoter Function in Disease Due to an Intracellular Pathogen
  187. Regulation of Nuclear Gamma Interferon Gene Expression by Interleukin 12 (IL-12) and IL-2 Represents a Novel Form of Posttranscriptional Control
  188. Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily
  189. Impaired NK Cell Development in an IFN-γ Transgenic Mouse: Aberrantly Expressed IFN-γ Enhances Hematopoietic Stem Cell Apoptosis and Affects NK Cell Differentiation
  190. Interleukin 18 (IL-18) in synergy with IL-2 induces lethal lung injury in mice: a potential role for cytokines, chemokines, and natural killer cells in the pathogenesis of interstitial pneumonia
  191. Adenovirus type 5 vectors induce dendritic cell differentiation in human CD14+ monocytes cultured under serum-free conditions
  192. Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes
  193. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization
  194. Human B Cell Activation by Autologous NK Cells Is Regulated by CD40-CD40 Ligand Interaction: Role of Memory B Cells and CD5+ B Cells
  195. Alternative splicing of the proadrenomedullin gene results in differential expression of gene products
  196. Correction: The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer
  197. The flavonoid baicalin inhibits superantigen‐induced inflammatory cytokines and chemokines
  198. Cutting Edge: IL-18-Transgenic Mice: In Vivo Evidence of a Broad Role for IL-18 in Modulating Immune Function
  199. Differential Regulation of Chemokine Gene Expression by 15-Deoxy-Δ12,1412,14 Prostaglandin J2
  200. Eotaxin (CCL11) Induces In Vivo Angiogenic Responses by Human CCR3+ Endothelial Cells
  201. Activating Ly-49 NK Receptors: Central Role in Cytokine and Chemokine Production
  202. Dampened SOCS: An altered balance between STAT activating and SOCS inhibitory signals regulate interferon-γ expression in LPMC
  203. Interleukin-3 Withdrawal Induces an Early Increase in Mitochondrial Membrane Potential Unrelated to the Bcl-2 Family
  204. Complete Regression of Established Spontaneous Mammary Carcinoma and the Therapeutic Prevention of Genetically Programmed Neoplastic Transition by IL-12/Pulse IL-2: Induction of Local T Cell Infiltration, Fas/Fas Ligand Gene Expression, and Mammary Epi...
  205. Functional Reconstitution and Regulation of IL-18 Activity by the IL-18Rβ Chain
  206. Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10
  207. Immortalized Myeloid Suppressor Cells Trigger Apoptosis in Antigen-Activated T Lymphocytes
  208. Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes
  209. In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells
  210. Human endothelial cells express CCR2 and respond to MCP-1: direct role of MCP-1 in angiogenesis and tumor progression
  211. A dual role for the -204 to -172 bp region of the IFN-Γ promoter: An activator of expression in LPL while a silencer of expression in PBL
  212. CD2-mediated activation of stat: transactivation of the lFN-Г intronic stat cis-element is unique for LPMC and independent of IL-12
  213. Indoleamine 2,3-Dioxygenase Production by Human Dendritic Cells Results in the Inhibition of T Cell Proliferation
  214. Interleukin-1 polymorphisms associated with increased risk of gastric cancer
  215. The Tryptophan Catabolite Picolinic Acid Selectively Induces the Chemokines Macrophage Inflammatory Protein-1α and -1β in Macrophages
  216. Mucosa-Specific Targets for Regulation of IFN-γ Expression: Lamina Propria T Cells Use Differentcis-Elements than Peripheral Blood T Cells to Regulate Transactivation of IFN-γ Expression
  217. Pathogen-specific loss of host resistance in mice lacking the IFN-γ-inducible gene IGTP
  218. Polymorphisms of the human IFNG gene noncoding regions
  219. IFN-γ-Dependent Delay of In Vivo Tumor Progression by Fas Overexpression on Murine Renal Cancer Cells
  220. Induction of STAT and NFκB activation by the antitumor agents 5,6-dimethylxanthenone-4-acetic acid and flavone acetic acid in a murine macrophage cell line
  221. Regulation of a Cell Type-specific Silencer in the Human Interleukin-3 Gene Promoter by the Transcription Factor YY1 and an AP2 Sequence-recognizing Factor
  222. CNS Interleukin-3 (IL-3) Expression and Neurological Syndrome in Antisense-IL-3 Transgenic Mice
  223. CCR5 Promoter Alleles and Specific DNA Binding Factors
  224. Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites
  225. Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Induce Expression of CXCR4 on Human Endothelial Cells
  226. Differential effects of the absence of interferon-gamma and IL-4 in acute graft-versus-host disease after allogeneic bone marrow transplantation in mice.
  227. Infection with Human Immunodeficiency Virus Type 1 Upregulates DNA Methyltransferase, Resulting in De Novo Methylation of the Gamma Interferon (IFN-γ) Promoter and Subsequent Downregulation of IFN-γ Production
  228. Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells
  229. Phenotypic and functional characterization of a panel of cytotoxic murine NK cell clones that are heterogeneous in their enhancement of Ig secretion in vitro
  230. Identification of both Cd2 enhancer and repressor elements within the interferon-λ promoter which regulate cytokine secretion in lamina propria T-cells
  231. Interaction of NF-κB and NFAT with the Interferon-γ Promoter
  232. Negative regulation of cytokine gene transcription 1
  233. Osteochondrodysplasia Occurring in Transgenic Mice Expressing Interferon-γ
  234. Identification of a Stat-6-responsive element in the promoter of the human interleukin-4 gene
  235. Apoptosis of L1210 leukemia cells induced by 3-deazaadenosine analogs: Differential expression of c-myc, NF-kappa B and molecular events
  236. Characterization of the MouseNktrGene and Promoter
  237. Bone Marrow and Thymus Expression of Interferon-γ Results in Severe B-Cell Lineage Reduction, T-Cell Lineage Alterations, and Hematopoietic Progenitor Deficiencies
  238. Molecular Regulation of Cytokine Gene Expression: lnterferon-γ as a Model System
  239. Interferon Expression by B Cells
  240. Retinoic Acid-induced Transcriptional Modulation of the Human Interferon-γ Promoter
  241. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
  242. The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element.
  243. Regulation of Interferon-γ Gene Expression
  244. Association of the expression of an SR-cyclophilin with myeloid cell differentiation
  245. Activation of Nuclear Factor of Activated T Cells in a Cyclosporin A-resistant Pathway
  246. Gradual Loss of T-Helper 1 Populations in Spleen of Mice During Progressive Tumor Growth
  247. Role of interferon-γ in immune cell regulation
  248. Cellular and molecular mechanisms of IFN-γ production induced by IL-2 and IL-12 in a human NK cell line
  249. Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2)
  250. Regulation of NK cells through the 80-kDa TNFR (CD120b)
  251. Regulation of interferon-γ gene transcription
  252. Cloning and characterization of a novel NK cell-specific serine protease gene and its functional 5?-flanking sequences
  253. Negative Transcriptional Regulation of the Interferon-γ Promoter by Glucocorticoids and Dominant Negative Mutants of c-Jun
  254. CD8+ and CD45RA+ human peripheral blood lymphocytes are potent sources of macrophage inflammatory protein 1α, interleukin‐8 and RANTES
  255. Comparison of lymphokine secretion and mRNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes
  256. Chromium(VI)-induced nuclear factor-кB activation in intact cells via free radical reactions
  257. Poor transduction efficiency of human hematopoietic progenitor cells by a high-titer amphotropic retrovirus producer cell clone
  258. Induction of Multiple Cytokine Gene Expression and IRF-1 mRNA by Flavone Acetic Acid in a Murine Macrophage Cell Line
  259. Identification of a DNA binding site for the nuclear factor YY1 in the human GM-CSF core promoter
  260. Two essential regulatory elements in the human interferon gamma promoter confer activation specific expression in T cells.
  261. Inhibition of tumor growth and enhancement of metastasis after transfection of the γ-interferon gene
  262. Localization of a Novel Natural Killer Triggering Receptor Locus to Human Chromosome 3p23-p21 and Mouse Chromosome 9
  263. The interleukin 2 CD28-responsive complex contains at least three members of the NF kappa B family: c-Rel, p50, and p65.
  264. A cyclophilin-related protein involved in the function of natural killer cells.
  265. Natural Killer (NK) Cell Lytic Dysfunction and Putative NK Cell Receptor Expression Abnormality in Members of a Family With Chromosome 3p-Linked von Hippel-Lindau Disease
  266. Cytokine Induction and Therapeutic Synergy with Interleukin-2 Against Murine Renal and Colon Cancers by Xanthenone-4-Acetic Acid Derivatives
  267. Kappa B site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel.
  268. Interferon-gamma gene expression in human B-cell lines: induction by interleukin-2, protein kinase C activators, and possible effect of hypomethylation on gene regulation
  269. Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo
  270. The c-rel protooncogene product c-Rel but not NF-kappa B binds to the intronic region of the human interferon-gamma gene at a site related to an interferon-stimulable response element.
  271. IL-7 regulation of cytotoxic lymphocytes: Pore-forming protein gene expression, interferon-γ production, and cytotoxicity of human peripheral blood lymphocyte subsets
  272. Comparative studies of CD3− and CD3+ CD56+ cells: Examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression
  273. In vivo distribution and cytokine gene expression by enriched mouse LAK effector cells
  274. Analysis of rat natural killer cytotoxic factor (NKCF): Mechanism of action and relationship to other cytotoxic/cytostatic factors
  275. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers.
  276. Differential regulation of interleukin-1 gene expression in human CD3− large granular lymphocytes
  277. Expression of human immunodeficiency virus long terminal repeat in the human promonocyte cell line U937: Effect of endotoxin and cytokines
  278. A model of human cytokine regulation based on transfection of gamma interferon gene fragments directly into isolated peripheral blood T lymphocytes.
  279. Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.
  280. Interferon-γ: Producer cells, activation stimuli, and molecular genetic regulation
  281. Interleukin 2-induced proliferation of murine natural killer cells in vivo.
  282. Interleukin-1 Costimulatory Activity on the Interleukin-2 Promoter Via AP-1
  283. Analysis of isotype switch variants of a Qa-5 specific hybridoma
  284. Enhanced responsiveness of human memory T cells to CD2 and CD3 receptor‐mediated activation
  285. The methylation state of the T cell antigen receptor β chain gene in subpopulations of mouse thymocytes
  286. CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines.
  287. Coordinate-Enhanced Expression of Three Adhesion Molecules (LFA-3, CD2, and LFA-1) and Three Other Molecules (4B4, UCHL1, and Pgp-1) Defines a Human T Cell Subset Containing Memory Cells and Characterized by Enhanced γ Interferon Production
  288. Rearrangement of both immunoglobulin and T-cell receptor genes in a prolymphocytic variant of hairy cell leukemia patient resistant to interferon-alpha [published erratum appears in Blood 1989 Feb;73(2):624]
  289. Immunomodulation of Natural Killer Cell Activity by Flavone Acetic Acid: Occurrence Via Induction of Interferon  /beta
  290. Characterization of Interleukin 2 and Phorbol Myristate Acetate Augmentation of Expression of Transfected Human Interferon-γ Genomic DNA
  291. Evidence that mouse promotion-sensitivity gene pro1 is transcribed by RNA polymerase III
  292. Modification of T cell receptor β chain gene: the J2 region but not the J1 region of the T cell receptor β chain gene is hypomethylated in human B cells and monocytes
  293. Detection of c-rel-related transcripts in mouse hematopoietic tissues, fractionated lymphocyte populations, and cell lines.
  294. Enhanced Interleukin-1 Production by Human Monocyte Cell Lines Following Treatment With 5-Azacytidine
  295. Detection of the intracellular ras p21 oncogene product by flow cytometry
  296. Posttranscriptional control of human gamma interferon gene expression in transfected mouse fibroblasts.
  297. Lack of gene rearrangement and mRNA expression of the beta chain of the T cell receptor in spontaneous rat large granular lymphocyte leukemia lines.
  298. Molecular cloning, genomic analysis, and biological properties of rat leukemia virus and the onc sequences of Rasheed rat sarcoma virus
  299. Induction of fibrosarcoma by rat sarcoma virus
  300. The p21 src genes of Harvey and Kirsten sarcoma viruses originate from divergent members of a family of normal vertebrate genes
  301. Analysis of two divergent rat genomic clones homologous to the transforming gene of Harvey murine sarcoma virus.
  302. Rat sarcoma virus: further analysis of individual viral isolates and the gene product
  303. Heteroduplex analysis of cloned rat endogenous replication-defective (30 S) retrovirus and Harvey murine sarcoma virus
  304. Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus
  305. Inhibition of Spontaneous Transformation of Rat Embryo Cells Releasing Endogenous Type C Virus by Virus-Specific Antiserum23
  306. p21 of Kirsten murine sarcoma virus is thermolabile in a viral mutant temperature sensitive for the maintenance of transformation
  307. Identification of a sarcoma virus-coded phosphoprotein in nonproducer cells transformed by Kirsten or Harvey murine sarcoma virus
  308. Different rat-derived transforming retroviruses code for an immunologically related intracellular phosphoprotein.
  309. Expression of RNA of an Endogenous Replication-Defective Retrovirus in Rat Mammary Adenocarcinomas Induced by 7,12-Dimethylbenz[a]anthracene2
  310. In vitro transcription of mouse mammary tumor virus RNA into DNA
  311. Physical map of the Kirsten sarcoma virus genome as determined by fingerprinting RNase T1-resistant oligonucleotides
  312. Friend strain of spleen focus-forming virus is a recombinant between ecotropic murine type C virus and the env gene region of xenotropic type C virus.
  313. In vitro transcription of Moloney leukemia virus genes in infected cell nuclei and chromatin: elongation of chromatin associated ribonucleic acid by Escherichia coli ribonucleic acid polymerase
  314. Steroid induction of mouse mammary tumor virus: effect upon synthesis and degradation of viral RNA
  315. Biochemical and physiological mechanisms in glucocorticoid hormone induction of mouse mammary tumor virus
  316. Effect of chemical inactivating agents on glucocorticoid receptor proteins in mouse and hamster cells.
  317. Changes in the levels of DNA-dependent RNA polymerases during the transition of the dimorphic fungus Mucor rouxii from yeast-like to mycelial growth
  318. Complementation of human adenovirus type 5 ts mutants by human adenovirus type 12
  319. Some observations on the cofactor requirement for partially purified DNA ligase from Escherichia coli
  320. Faculty of 1000 evaluation for Temporal response of the human virome to immunosuppression and antiviral therapy.
  321. IFN-γ: Recent Advances in Understanding Regulation of Expression, Biological Functions, and Clinical Applications